A morphological study of an amphotericin B emulsion-based delivery system

International Journal of Pharmaceutics

Volumn 145, Issue 1-2, 1996, Pages 17-27

  Do Egito, E S Tabosa ^a   Fessi, H ^a   Appel, M ^a   Barratt, G ^a   Legrand, P ^a   Bolard, J ^b   Devissaguet, J Ph ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Absorption spectra; Amphotericin B; Circular dichroism spectra; Spontaneous emulsification; Submicronic emulsions

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; LIPOID E80; MEDIUM CHAIN FATTY ACID; MYGLIOL 812; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; EMULSION; MORPHOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0030573063     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04713-8     Document Type: Article

References (32)

1. Barnhart, E.R., Fungizone Intravenous Physicians' Desk Reference, 39th edn, Medical Economics, Oradell, NJ, 1985, pp. 1994-1996.
2. Bodey, G.P., Fungal infections complicating acute leukemia. J. Chronic Dis., 19 (1966) 667-687.
3. Bodey, G.P., Infectious complications in the cancer patient. Curr. Probl. Cancer, 1 (1977) 1-63.
4. Bolard, J., Seigneuret, M. and Boudet, G., Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Lipid state and cholesterol content dependence. Biochim. Biophys. Acta, 599 (1980) 280-293.
5. Davis, S.S. and Washington, C., Surfactant-stabilized drug emulsion. Eur. Patent Applied EP 296 (1988) 845.
6. De Kruijff, B. and Demel, R.A., Polyene antibiotic-sterol interactions in membranes of acholeplasma laidlawii cells and lecithin liposomes. III-Molecular structure of the polyene antibiotic-cholesterol complex. Biochim. Biophys. Acta, 339 (1974) 57-70.
7. Ernst, C., Grange, J., Rinnert, H., Dupont, G. and Lematre, J., Structure of amphotericin B aggregates as revealed by UV and CD spectroscopies. Biopolymers. 20 (1981) 1575-1588.
8. Gondal, J.A., Swartz, R.P, and Rahman, A., Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic Candidiasis in mice. Antimicrob. Agents Chemother., 33 (1989) 1544-1548.
9. Graybill, J.R., Craven, P.C., Taylor, R.L., Williams, D.M. and Magee, W.E., Treatment of murine Cryptococcosis with liposome-associated amphotericin B. J. Infect. Dis., 145 (1982) 748-752.
10. Janoff, A.S., Boni, LT., Popescu, M.C., Minchey, S.R., Cullis, P.R., Madden, T.D., Taraschi, T., Gruner, S.M., Shyamsunder, E., Tate, M.W., Mendelsohn, R. and Bonner, D., Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. USA, 85 (1988) 6122-6126.
11. Jullien, S., Brajtburg, J. and Bolard, J., Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in-vitro cellular toxicity of liposomal preparations. Biochim. Biophys. Acta, 1021 (1990) 39-45.
12. Jullien, S., Contrepois, A., Sligh, J.E., Domart, Y., Yeni, P., Brajtburg, J., Medoff, G. and Bolard, J., Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids. Antimicrob. Agents Chemother., 33 (1989) 345-349.
13. Kirsh, R., Goldstein, R., Tarloff, J., Parris, D., Hook, J., Hanna, N., Bugelski, P. and Poste, G., An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J. Infect. Dis., 158, 5 (1988) 1065-1070.
14. Krick, J.A. and Remington, J.S., Opportunistic invasive fungal infections in patients with leukaemia and lymphoma. Clin. Lab. Haematol., 5 (1976) 249-310.
15. Lamy-Freund, M.T., Schreier, S., Peitzsch, R.M. and Reed, W. F., Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering. J. Pharm. Sci., 80 (1991) 262-266.
16. Lopez-Berestein, G., Liposomes as carriers of antimicrobial agents. Antimicrob. Agents Chemother., 31 (1987) 675-678.
17. Lopez-Berestein, G., Hopfer, R.L., Mehta, R., Mehta, K., Hersh, E.M. and Juliano, R.L., Liposome-encapsulated amphotericin B for treatment of disseminated Candidiasis in neutropenic mice. J. Infect. Dis., 150 (1984) 278-283.
18. Lopez-Berestein, G., Mehta, R., Hopfer, R.L., Mills, K., Kasi, L., Mehta, K., Fainstein, V., Luna, M., Hersh, E.M. and Juliano, R., Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J. Infect. Dis., 147 (1983) 939-945.
19. Mazerski, J., Bolard, J. and Borowski, E., Self-association of some polyene macrolide antibiotics in aqueous media. Biochim. Biophys. Acta, 719 (1982) 11-17.
20. Mazerski, J., Grzybowska, J. and Borowski, E., Influence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous media. Eur. Biophys. J., 18 (1990) 159-164.
21. Mehta, R., Lopez-Berestein, G., Hopfer, R., Mills, K. and Juliano, R.L., Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim. Biophys. Acta, 770 (1984) 230-234.
22. Perfect, J.R., Pickard, W.W., Hunt, D.L., Palmer, B. and Schell, W.A., The use of amphotericin B in nosocomial fungal infection. Rev. Infect. Dis., 13 (1991) 474-479.
23. Singer, C., Kaplan, M.H. and Armstrong, D., Bacteremia and fungemia complicating neoplastic disease, A study of 364 cases. Am. J. Med., 62 (1977) 731-742.
24. Souza, L.C., Maranhao, R.C., Schreier, S. and Campa, A., In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion. J. Antimicrob. Chemother., 32 (1993) 123-132.
25. Speller, D.C.E. and Warnock, D.D., Liposomal amphotericin B (AmBisome) in the treatment of systemic fungal infection, Based on paper presented at a symposium in Stratford-on-Avon, UK, March. J. Antimicrob. Chemother., (1991) 28, Suppl. B.
26. Strauss, G. and Kral, F., Borate complexes of amphotericin B: Polymeric species and aggregates in aqueous solutions. Biopolymers, 21 (1982) 459-470.
27. Tabosa do Egito, E.S., Fessi, H., Appel, M., Puisieux, F., Bolard, J. and Devissaguet, J-P., New techniques for preparing submicronic emulsions: Application to amphotericin B. S.T.P. Pharma Sci., 4 (1994) 155-162.
28. Tabosa do Egito, E.S., Appel, M., Fessi, H., Barratt, G., Puisieux, F. and Devissaguet, J-P., In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system. J. Antimicrob. Chemother., 38 (1996) in press.
29. Tyle, P. and Frank, S.G., Phytosterol stabilized emulsions: Correlation between rheologic and calorimetric studies. Drug Dev. Ind. Pharm., 17(8) (1991) 1131-1141.
30. Verhoeff, J., Peterson, P.K. and Quie, P.G. (Eds.), Infections in the Immunocompromised Host Pathogenesis, Prevention and Therapy, Elsevier, North-Holland, Amsterdam, 1980.
31. Washington, C., Taylor, S.J. and Davis, S.S., The structure of colloidal formulations of amphotericin B. Int. J. Pharm., 46 (1988) 25-30.
32. Winston, D.J., Gale, R.P., Meyer, D.V. and Young, L.S., Infectious complications of human bone marrow transplantation. Medicine (Baltimore), 58 (1979) 1-31.